Janus Capital Group
Janus provides growth and risk-managed investment strategies and manages equity, fixed income, money market, and balanced mutual funds.
Business Model:
Revenue: $1.4B
Employees: 1,001-5,000
Rankings
Detailed Janus Capital Group Information
Geographic Data
Address: 151 Detroit St
City: Denver
State: CO
Zip: 80206
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Janus Capital Group is a global investment management firm managing $160 billion in global assets through product offerings across growth, mathematical, value and fixed-income. They work hard, think smart, and exist to create success for their clients.
Contact Phone:
+13033333863
Contact Email:
Janus Capital Group went public on 7/7/2000 on the NYSE
Listed Exchange:
NYSE
IPO Date:
7/7/2000
Ticker Symbol:
JNS
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 6/2006 | MediQuest Therapeutics | Series A | 0 |
| 6/2000 | Plumtree Software | Venture Round | 23M |
| 4/2014 | Sierra Oncology | Series D | 0 |
| 5/2013 | Apptio | Series E | 45M |
| 1/2015 | Aduro BioTech | Series D | 51.4M |
| 10/2011 | Workday | Series F | 85M |
| 3/2018 | Bigfoot Biomedical | Series B | 0 |
| 7/2017 | Silk Road Medical | Series C | 0 |
| 9/2015 | Intellia Therapeutics | Series B | 0 |
| 6/2015 | Clementia Pharmaceuticals | Venture Round | 0 |
| 9/2015 | AveXis | Series D | 65M |
| 12/2015 | Lyft | Series F | 0 |
| 7/2008 | Portola Pharmaceuticals | Series C | 60.1M |
| 5/2015 | REGENXBIO | Series D | 0 |
| 3/2017 | Solid Biosciences | Series C | 0 |
| 2/2021 | Highview Power | Corporate Round | - |
| 6/2014 | Okta | Series E | 75M |
| 4/2015 | Edge Therapeutics | Series C | 56M |
| 2/2021 | Highview Power | Corporate Round | - |
| 3/2018 | Bigfoot Biomedical | Series B | 0 |
| 7/2017 | Silk Road Medical | Series C | 0 |
| 3/2017 | Solid Biosciences | Series C | 0 |
| 12/2015 | Lyft | Series F | 0 |
| 9/2015 | AveXis | Series D | 0 |
| 9/2015 | Intellia Therapeutics | Series B | 0 |
| 6/2015 | Clementia Pharmaceuticals | Venture Round | 0 |
| 5/2015 | REGENXBIO | Series D | 0 |
| 4/2015 | Edge Therapeutics | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
